psychiatryПСИХИАТРИЯPsychiatry (Moscow) (Psikhiatriya)1683-83192618-6667FSBSI “The Mental Health Research Centre”; LLC «Publisher «MIA»10.30629/2618-6667-2021-19-1-90-101psychiatry-590Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWSЭндогенные маниакально-парафренные состоянияEndogenous Manic-Paraphrenic Stateshttps://orcid.org/0000-0002-8213-5122СизовС. В.SizovS. V.

научный сотрудник, отдел по изучению эндогенных психических расстройств и аффективных состояний

Москва

Department of Endogenous Mental Disorders and Affective Conditions

Moscow

sizov.stepan@list.ruhttps://orcid.org/0000-0002-8344-0620ОлейчикИ. В.OleichikI. V.

доктор медицинских наук, отдел по изучению эндогенных психических расстройств и аффективных состояний

Москва

MD, PhD, Dr. of Sci. (Med.), Principal Researcher, Department of Endogenous Mental Disorders and Affective Conditions, Mental Health Research Centre

Moscow

i.oleichik@mail.ruhttps://orcid.org/0000-0002-4423-4007БарановП. А.BaranovP. A.

кандидат медицинских наук, научный сотрудник, отдел по изучению эндогенных психических расстройств и аффективных состояний

Москва

MD, PhD, Cand. of Sci. (Med.), Researcher, Department for the Study of Endogenous Mental Disorders and Affective Conditions

Moscow

pab1960@mail.ruФГБНУ «Научный центр психического здоровья»РоссияFSBSI “Mental Health Research Centre”Russian Federation20212803202119190101Copyright © Сизов С.В., Олейчик И.В., Баранов П.А., 20212021Сизов С.В., Олейчик И.В., Баранов П.А.Sizov S.V., Oleichik I.V., Baranov P.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.journalpsychiatry.com/jour/article/view/590Цель работы

Цель работы: анализ изменения взглядов отечественных и зарубежных исследователей на клинические и биологические особенности маниакально-парафренных состояний, развивающихся в рамках эндогенных приступообразных психозов.

Материал и метод

Материал и метод: по ключевым словам «мания, парафрения, manic, paraphrenic», «маниакально-парафренное состояние» отобраны доступные авторам публикации в базах  MEDLINE/PubMed, Scopus, Webofscience, eLibrary.

Заключение

Заключение: выделены следующие направления исследований: 1) распространенность маниакально- парафренных состояний в настоящее время; 2) эволюция представлений исследователей в отношении данных психозов  на протяжении всего периода изучения вопроса; 3)  современная точка зрения на нозологическую принадлежность  маниакально-парафренных состояний и их  место в классификациях психических расстройств, используемых в настоящее время; 4) актуальные вопросы  патогенеза подобных расстройств.

Purpose of the work

Purpose of the work: analysis of changes in the views of domestic and foreign researchers on the clinical and biological features of manic-paraphrenic states developing within the framework of endogenous  paroxysmal states psychoses.

Material and method

Material and method: by the keywords “mania, paraphrenia, manic,  paraphrenic”, “manic-paraphrenic state”, publications available to authors were selected in the databases MEDLINE/PubMed, Scopus, Webofscience, eLibrary.

Conclusion

Conclusion: the following areas of research have been identified: 1) the prevalence of manic-paraphrenic states at the present time; 2) evolution of researchers’ opinions regarding these psychoses throughout the entire period of the study of the issue; 3) a modern point of view on the nosology of manic-paraphrenic states and their place in current classifications of  mental disorders; 4) topical issues of the pathogenesis of such disorders.

парафренияманиакально-парафренные состоянияманиакально-бредовые состояниятипологияприст упообразная шизофренияшизоаффективное расстройствобиполярное аффективное расстройствоparaphreniamanic-paraphrenic statesmanic-delusional statestypologyparoxysmal schizophreniaschizoaffective disorderbipolar disorderReferencesТочилов ВА. О трудностях в диагностике и лечении атипичных аффективных психозов. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 1992;4:28–36.Tochilov VA. O trudnostiakh v diagnostike i lechenii atipichnykh affektivnykh psikhozov. Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V.M. Bekhtereva. 1992;4:28–36. (In Russ.).Пашковский ВЭ. Клинические особенности бреда мессианства при психических расстройствах шизофренического спектра. Журнал неврологии и психиатрии имени С.С. Корсакова. 2006;106(4):15–20.Pashkovskii VE. Klinicheskie osobennosti breda messianstva pri psikhicheskikh rasstroistvakh shizofrenicheskogo spektra. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2006;106(4):15–20. (In Russ.).Субботская НВ. Психопатология острого парафренного синдрома и его типологические варианты. Психиатрия. 2005;5:26–31.Subbotskaya NV. Psychopathology of acute paraphrenic syndrome and its typological variants. Psychiatry. 2005;5:26–31. (In Russ.).Соколов АВ. Психопатологические особенности бреда преувеличенной самооценки в картине эндогенных маниакально-бредовых состояний. Журнал неврологии и психиатрии имени С.С. Корсакова. 2012;112(2):18–24.Sokolov AV. Psychopathological features and delusion of exaggerated self-esteem in endogenous manic-delusion states. Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. 2012;112(2):18–24. (In Russ.).Шумский НГ. К клинике парафренной (фантастически- параноидной) шизофрении. Журнал невропатологии и психиатрии имени С.С. Корсакова. 1958;4:462–470.Shumskij NG. K klinike parafrennoj (fantasticheski-paranoidnoj) shizofrenii. Zhurnal nevropatologii i psixiatrii imeni S.S. Korsakova. 1958;58(4):462–470. (In Russ.).Тиганов АС. Некоторые особенности маниакальных состояний при шизофрении, протекающей в форме шубов. Журнал невропатологии и психиатрии имени С.С. Корсакова. 1969;69;2:249–253.Tiganov AS. Concerning of the features of maniac states occurring in schizophrenia of the shiftlike form. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1969;69(2):249–253. (In Russ.).Соколова БВ. К клинике и психопатологии острых парафренных состояний. Журнал невропатологии и психиатрии имени С.С. Корсакова. 1968;5:754–758.Sokolova BV. The clinical picture and psychopathology of acute paraphrenic states in schizophreniа. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1968;5:754–758. (In Russ.).Снежневский АВ. Клиническая психопатология. Руководство по психиатрии. Под ред. А.В. Снежневского. М., 1983;Т. 1:16–80.Snezhnevskii AV. Klinicheskaia psikhopatologiia. Rukovodstvo po psikhiatrii. Pod red. A.V. Snezhnevskogo. M., 1983;T.1:16–80. (In Russ.).Appelbaum P, Clark Robbins P, Roth Loren H. Dimensional Approach to Delusions: Comparison Across Types and Diagnoses. The American Journal of psychiatry. 1999;156:1938–1943. DOI: 10.1176/ajp.156.12.1938Appelbaum P, Clark Robbins P, Roth Loren H. Dimensional Approach to Delusions: Comparison Across Types and Diagnoses. The American Journal of psychiatry. 1999;156:1938–1943. DOI: 10.1176/ajp.156.12.1938Casanova M. The Pathology of Paraphrenia. Current Psychiatry Reports. 2010;12:196–201. DOI: 10.1007/s11920-010-0108-8Casanova M. The Pathology of Paraphrenia. Current Psychiatry Reports. 2010;12:196–201. DOI: 10.1007/s11920-010-0108-8Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br. J. Psychiatry. 2003;183:213–219. DOI: 10.1192/bjp.183.3.213. PMID: 12948993Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br. J. Psychiatry. 2003;183:213–219. DOI: 10.1192/bjp.183.3.213. PMID: 12948993Girard C. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. The American Journal of Geriatric Psychiatry. 2008:16(6):478–487. DOI: 10.1097/JGP.0b013e31816c7b3cGirard C. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. The American Journal of Geriatric Psychiatry. 2008:16(6):478–487. DOI: 10.1097/JGP.0b013e31816c7b3cHoward R, Rabins P. Late paraphrenia revisited. Br. J. Psychiatry. 1997;171:406–408. DOI: 10.1192/bjp.171.5.406. PMID: 9463595Howard R, Rabins P. Late paraphrenia revisited. Br. J. Psychiatry. 1997;171:406–408. DOI: 10.1192/bjp.171.5.406. PMID: 9463595Reeves RR, Brister JC. Psychosis in late life: emerging issues. J. Psychosoc. Nurs. Ment. Health Serv. 2008;46(11):45–52. DOI: 10.3928/02793695-20081101-09. PMID: 19051578Reeves RR, Brister JC. Psychosis in late life: emerging issues. J. Psychosoc. Nurs. Ment. Health Serv. 2008;46(11):45–52. DOI: 10.3928/02793695-20081101-09. PMID: 19051578Yamada M. Senile Dementia of the Neurofibrillary Tangle Type (SD-NFT). Brain Nerve. 2018;5(70):533–541. DOI: 10.11477/mf.1416201035Yamada M. Senile Dementia of the Neurofibrillary Tangle Type (SD-NFT). Brain Nerve. 2018;5(70):533–541. DOI: 10.11477/mf.1416201035Conus P, Cotton S, Bechdolf A, Nelson B, Chenen A. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. Journal of Affective Disorder. 2010;1(127):316–320. DOI: 10.1016/j.jad.2010.06.016Conus P, Cotton S, Bechdolf A, Nelson B, Chenen A. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. Journal of Affective Disorder. 2010;1(127):316–320. DOI: 10.1016/j.jad.2010.06.016Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008;10(1Pt.2):215–230. DOI: 10.1111/j.1399-5618.2007.00564.x PMID: 18199238Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008;10(1Pt.2):215–230. DOI: 10.1111/j.1399-5618.2007.00564.x PMID: 18199238van Os, J, Kapur S. Schizophrenia. Lancet. 2009;22(374):635–645. DOI: 10.1016/S0140-6736(09)60995-8van Os, J, Kapur S. Schizophrenia. Lancet. 2009;22(374):635–645. DOI: 10.1016/S0140-6736(09)60995-8Roy M, Neale M, Kendler K. The Genetic Epidemiology of Self-Esteem. Br. J. Psychiatry. 1995;166(6):813–820. DOI: 10.1192/bjp.166.6.813Roy M, Neale M, Kendler K. The Genetic Epidemiology of Self-Esteem. Br. J. Psychiatry. 1995;166(6):813–820. DOI: 10.1192/bjp.166.6.813Torrent C, Martínez-Arán A, Amann B, Daban C, Tabarés-Seisdedos R, González-Pinto A. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr. Scand. 2007;6(116):453–460. DOI: 10.1111/j.1600-0447.2007.01072.xTorrent C, Martínez-Arán A, Amann B, Daban C, Tabarés-Seisdedos R, González-Pinto A. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr. Scand. 2007;6(116):453–460. DOI: 10.1111/j.1600-0447.2007.01072.xBech P, BolwigТ, Kramp P, Rafaelsen O. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Psychiatr. Pol. 2011;45(1):61–78.Bech P, BolwigТ, Kramp P, Rafaelsen O. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Psychiatr. Pol. 2011;45(1):61–78.Świtaj P, Grygiel P, Chrostek A, Wciórka J. Investigating the Roles of Loneliness and Clinician- And Self-Rated Depressive Symptoms in Predicting the Subjective Quality of Life Among People With Psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2018;53(2):183–193. DOI: 10.1007/s00127-017-1470-1Świtaj P, Grygiel P, Chrostek A, Wciórka J. Investigating the Roles of Loneliness and Clinician- And Self-Rated Depressive Symptoms in Predicting the Subjective Quality of Life Among People With Psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2018;53(2):183–193. DOI: 10.1007/s00127-017-1470-1Bentall R, Rowse G, Shryane N. The cognitive and affective structure of paranoid delusions. A transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch. Gen. Psychiatry. 2009;66:236–247. DOI: 10.1001/archgenpsychiatry.2009.1Bentall R, Rowse G, Shryane N. The cognitive and affective structure of paranoid delusions. A transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch. Gen. Psychiatry. 2009;66:236–247. DOI: 10.1001/archgenpsychiatry.2009.1Beck AT, Rector NA. Cognitive approaches to schizophrenia: theory and therapy. Annu. Rev. Clin. Psychol. 2005;1:577–606. DOI: 10.1146/annurev.clinpsy.1.102803.144205 PMID: 17716100Beck AT, Rector NA. Cognitive approaches to schizophrenia: theory and therapy. Annu. Rev. Clin. Psychol. 2005;1:577–606. DOI: 10.1146/annurev.clinpsy.1.102803.144205 PMID: 17716100Horowitz MJ. A cognitive model of hallucinations. Am. J. Psychiatry. 1975;132(8):789–795. DOI: 10.1176/ajp.132.8.789. PMID: 1147062Horowitz MJ. A cognitive model of hallucinations. Am. J. Psychiatry. 1975;132(8):789–795. DOI: 10.1176/ajp.132.8.789. PMID: 1147062Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a review. Soc. Psychiatry Psychiatr Epidemiol. 2014;49:1179–1189. DOI: 10.1007/s00127-014-0928-7Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a review. Soc. Psychiatry Psychiatr Epidemiol. 2014;49:1179–1189. DOI: 10.1007/s00127-014-0928-7Garety P, Fowler A, Bebbington P, Freeman D. A cognitive model of the positive symptoms of psychosis. Psychol. Med. 2001;2(31):189–195. DOI: 10.1017/s0033291701003312Garety P, Fowler A, Bebbington P, Freeman D. A cognitive model of the positive symptoms of psychosis. Psychol. Med. 2001;2(31):189–195. DOI: 10.1017/s0033291701003312Morrison H, Welgus H, Stockley R, Birnett D. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. American Journal of Respiratory Cell and Molecular Biology. 1990;2:263–269.Morrison H, Welgus H, Stockley R, Birnett D. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. American Journal of Respiratory Cell and Molecular Biology. 1990;2:263–269.Swann AC, Janicak PL, Calabrese JR, Bowden CL, Dilsaver SC, Morris DD, Petty F, Davis JM. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J. Affect. Disord. 2001;67(1–3):123–132. DOI: 10.1016/s0165-0327(01)00447-5. PMID: 11869759Swann AC, Janicak PL, Calabrese JR, Bowden CL, Dilsaver SC, Morris DD, Petty F, Davis JM. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J. Affect. Disord. 2001;67(1–3):123–132. DOI: 10.1016/s0165-0327(01)00447-5. PMID: 11869759Krabbendam L, Myin-Germeys I, De Graaf R, Vollebergh W, Nolen WA, Iedema J, van Os J. Dimensions of depression, mania and psychosis in the general population. Psychol. Med. 2004;34(7):1177–1186. DOI: 10.1017/s0033291703001892 PMID: 15697044Krabbendam L, Myin-Germeys I, De Graaf R, Vollebergh W, Nolen WA, Iedema J, van Os J. Dimensions of depression, mania and psychosis in the general population. Psychol. Med. 2004;34(7):1177–1186. DOI: 10.1017/s0033291703001892 PMID: 15697044Azorin J, Akiskal H, Hentouche E. The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. J. Affect. Disord. 2006;96:215–223.Azorin J, Akiskal H, Hentouche E. The mood-instability hypothesis in the origin of mood-congruent versus mood-incongruent psychotic distinction in mania: validation in a French National Study of 1090 patients. J. Affect. Disord. 2006;96:215–223.Berrios G. Is the concept of “dimension” applicable to psychiatric objects? World Psychiatry. 2013;1(12):76–78. DOI: 10.1002/wps.20019Berrios G. Is the concept of “dimension” applicable to psychiatric objects? World Psychiatry. 2013;1(12):76–78. DOI: 10.1002/wps.20019Andreasen N. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophrenia Bulletin. 2007;1(33):8–12. DOI: 10.1093/schbul/sbl054Andreasen N. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophrenia Bulletin. 2007;1(33):8–12. DOI: 10.1093/schbul/sbl054Савенко ЮС. Можно ли исчерпать психопатологию? Независимый психиатрический журнал. 2016;3:29–32.Savenko IuS. Mozhno li ischerpat’ psikhopatologiiu? Nezavisimyi psikhiatricheskii zhurnal. 2016;3:29–32. (In Russ.).Knowles R, McCarthy-Jones S, Rowse G. Grandiose delusions: A review and theoretical integration of cognitive and affective perspectives. Clinical Psychology Review. 2011;31(4):684–696. DOI: 10.1016/j.cpr.2011.02.009Knowles R, McCarthy-Jones S, Rowse G. Grandiose delusions: A review and theoretical integration of cognitive and affective perspectives. Clinical Psychology Review. 2011;31(4):684–696. DOI: 10.1016/j.cpr.2011.02.009Radermaker S, Sirois F. Late paraphrenia: an accidental finding. Presse Med. 2013;42(5):911–912. DOI: 10.1016/j.lpm.2012.06.018Radermaker S, Sirois F. Late paraphrenia: an accidental finding. Presse Med. 2013;42(5):911–912. DOI: 10.1016/j.lpm.2012.06.018Jacobowski NL, Heckers S, Bobo WV. Delirious mania: detection, diagnosis, and clinical management in the acute setting. J. Psychiatr. Pract. 2013;19(1):15–28. DOI: 10.1097/01.pra.0000426324.67322.06. PMID: 23334676Jacobowski NL, Heckers S, Bobo WV. Delirious mania: detection, diagnosis, and clinical management in the acute setting. J. Psychiatr. Pract. 2013;19(1):15–28. DOI: 10.1097/01.pra.0000426324.67322.06. PMID: 23334676Морозова МА. Клиника, течение и прогноз аффективного психоза, протекающего с преобладанием маниакальных расстройств. Журнал невропатологии и психиатрии имени С.С. Корсакова. 1989;89(4):82–87.Morozova MA. Clinic, course and prognosis of affective psychosis, proceeding with a predominance of manic disorders. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova. 1989;89(4):82–87. (In Russ.).Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Dosage of haloperidol for mania. Br. J. Psychiatry. 1994;165(1):113–116. DOI: 10.1192/bjp.165.1.113 PMID: 7953013Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Dosage of haloperidol for mania. Br. J. Psychiatry. 1994;165(1):113–116. DOI: 10.1192/bjp.165.1.113 PMID: 7953013Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J. Affect. Disord. 2007;103(1–3):5–11. DOI: 10.1016/j.jad.2007.05.019 Epub. 2007 Jul 12. PMID: 17628692Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. J. Affect. Disord. 2007;103(1–3):5–11. DOI: 10.1016/j.jad.2007.05.019 Epub. 2007 Jul 12. PMID: 17628692Воробьев РВ. Клиническая типология смешанных маниакальных состояний при биполярном аффективном расстройстве. Российский психиатрический журнал. 2014;1:33–42.Vorobyev RV. Clinical typology of mixed mania in bipolar affective disorder. Russian Psychiatric Journal. 2014;1:33–42. (In Russ.).Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br. J. Psychiatry. 2006;188:122–127. DOI: 10.1192/bjp.188.2.122. PMID: 16449697Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br. J. Psychiatry. 2006;188:122–127. DOI: 10.1192/bjp.188.2.122. PMID: 16449697Смулевич АБ. Депрессии в общей медицине. Руководство для врачей. М.: Медицинское информационное агентство, 2001.Smulevich AB. Depressii v obshchei meditsine. Rukovodstvo dlia vrachei. M.: Meditsinskoe informatsionnoe agentstvo, 2001. (In Russ.).Бубнова ЮС, Дорофейков ВВ, Мазо ГЭ, Петрова НН. К вопросу о механизмах развития депрессии при шизофрении. Психиатрия и психофармакотерапия. 2012;4(14):21–26.Bubnova, US, Dorofeykov VV, Maso GE, Petrova NN. To the question of the mechanisms of development of depression in schizophrenia. Psihiatriya i psihofarmakoterapiya. 2012;4(14):21–26. (In Russ.).Петрова НН. Антипсихотики — основные средства лечения шизофрении и других психозов. Фундаментальные аспекты психического здоровья. 2016;3:124–134.Petrova NN. Antipsychotics are the main treatment for schizophrenia and other psychoses. Fundamentalnye aspekty psihicheskogo zdorovya. 2016;3:124–134. (In Russ.).Barnes T, McPhillips M. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease- related negative symptoms in schizophrenia. International clinical psychopharmacology. 1995;10(3):115–121.Barnes T, McPhillips M. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease- related negative symptoms in schizophrenia. International clinical psychopharmacology. 1995;10(3):115–121.Karamatskos E, Mulert C, Lambert M, Naber D. Subjective well-being of patients with schizophrenia as a target of drug treatment. Curr. Pharm. Biotechnol. 2012;13(8):1490–1499. DOI: 10.2174/138920112800784862 PMID: 22283757Karamatskos E, Mulert C, Lambert M, Naber D. Subjective well-being of patients with schizophrenia as a target of drug treatment. Curr. Pharm. Biotechnol. 2012;13(8):1490–1499. DOI: 10.2174/138920112800784862 PMID: 22283757Crismon M, Argo T, Bendele S, Suppes T. Texas Medication Algorithm Project Procedural Manual: Bipolar Disorder Algorithms. The Texas Department of State Health Services. 2007:66.Crismon M, Argo T, Bendele S, Suppes T. Texas Medication Algorithm Project Procedural Manual: Bipolar Disorder Algorithms. The Texas Department of State Health Services. 2007:66.Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation. 2013;10:43. DOI: 10.1186/1742-2094-10-43 PMID: 23547920; PMCID: PMC3626880Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation. 2013;10:43. DOI: 10.1186/1742-2094-10-43 PMID: 23547920; PMCID: PMC3626880Клюшник ТП, Омельченко МА, Сарманова ЗВ, Зозуля СА, Отман ИН, Дупин АМ, Каледа ВГ. Возможность использования иммунологических показателей для оценки риска манифестации эндогенных психозов у больных с непсихотическими расстройствами юношеского возраста. Журнал неврологии и психиатрии имени С.С. Корсакова. 2014;114(10):97–101.Klyushnik TP, Omelchenko MA, Sarmanova ZV, Zozulya SA, Otman IN, Dupin AM, Kaleda VG. Possibilities of the use of immunological indicators for the assessment of the risk of manifestation of endogenous psychoses in patients with nonpsychoticdisorders of the juvenile age. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114(10):97–101. (In Russ.).Small J, Milstein V, Malloy F, Medlock C, Klapper M. Clinical and quantitative EEG studies of mania. J. Affect. Disord. 1999;53:217–224. DOI: 10.1016/S0165-0327(98)00124-4Small J, Milstein V, Malloy F, Medlock C, Klapper M. Clinical and quantitative EEG studies of mania. J. Affect. Disord. 1999;53:217–224. DOI: 10.1016/S0165-0327(98)00124-4Изнак АФ, Изнак ЕВ, Клюшник ТП, Пантелеева ГП, Олейчик ИВ, Абрамова ЛИ, Столяров СА. Нейрофизиологические и нейроиммунологические показатели прогноза эффективности терапии аффективно-бредовых состояний в рамках приступообразной шизофрении. Психиатрия. 2014;2:47–52.Iznak AF, Iznak EV, Klushnik TP, Panteleeva GP, Oleichik IV, Abramova LI, Stolyarov SA. Neurophysiological and neuroimmunological indicators for predicting the effectiveness of therapy for affective-delusional conditions in the context of paroxysmal schizophrenia. Psychiatry. 2014;2:47–52. (In Russ.).Брусов ОС, Матвеев ИА, Кириллов ПС, Фактор МИ, Карпова НС, Васильева ЕФ, Катасонов АБ, Зозуля СА, Клюшник ТП. Оценка риска тромботических нарушений у больных шизофренией и шизоаффективными расстройствами в остром периоде болезни с использованием технологии «фибринодинамика». Журнал неврологии и психиатрии имени С.С. Корсакова. 2017;117(11):91–100. DOI: 10.17116/jnevro201711711191-100Brusov OS, Matveev IA, Kirillov PS, Faktor MI, Karpova NS, Vasil’eva EF, Katasonov AB, Zozulya SA, Klyushnik TP. Risk assessment of thrombotic events in patients with schizophrenia and schizoaffective disorder in the acute state: the “fibrinodynamics” technology. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(11):91–100. (In Russ.). DOI: 10.17116/jnevro201711711191-100Мелешко ТК, Критская ВП. К проблеме специфичности шизофренической патологии. Психиатрия. 2016;72(4):20–26.Meleshko TK, Kritskaya VP. Towards the problem of pecularites of schizophrenic pathology. Psychiatry. 2016;72(4):20–26. (In Russ.).Изнак АФ, Изнак ЕВ, Клюшник ТП, Олейчик ИВ, Абрамова ЛМ, Кобельков ГМ, Ложников МА. Регрессионные модели взаимосвязей клинических и нейробиологических показателей при терапии маниакально-бредовых состояний в рамках приступообразной шизофрении. Журнал неврологии и психиатрии имени С.С. Корсакова. 2016;116(3):33–38. DOI: 10.17116/jnevro20161163133-38Iznak AF, Iznak EV, Klushnik TP, Oleichik IV, Abramova LM, Kobelkov GM, Lozhnikov MA. Regression models of the relationship of clinical and neurobiological parameters in the treatment of manic- delusional conditions in the context of paroxysmal schizophrenia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2016;116(3):33–38. (In Russ.). DOI: 10.17116/jnevro20161163133-38Зозуля СА, Олейчик ИВ, Андросова ЛВ, Отман ИН, Сарманова ЗВ, Столяров СА, Бизяева АС, Юнилайнен ОА, Клюшник ТП. Мониторинг течения эндогенных психозов по иммунологическим показателям. Психическое здоровье. 2017;15(1):11–18.Zozulya SA, Oleichik IV, Androsova LV, Otman IN, Sarmanova ZV, Stolyarov SA, Bizyaeva AS, Unilaynen OA, Klyushnik TP. Monitoring trand of endogenous psychoses by immunological indicators. Psihicheskoe zdorov’e. 2017;15(1):11–18. (In Russ.).Raison CL, Capuron L, Miller AH. Cytokines sing the blues: infl ammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31. DOI: 10.1016/j.it.2005.11.006 Epub 2005 Nov 28. PMID: 16316783; PMCID: PMC3392963Raison CL, Capuron L, Miller AH. Cytokines sing the blues: infl ammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31. DOI: 10.1016/j.it.2005.11.006 Epub 2005 Nov 28. PMID: 16316783; PMCID: PMC3392963Hoir isch-Cl apauch S, Nardi AE, Gr is JC, Brenner B. Mental disorders and thrombotic risk. Semin. Thromb. Hemost. 2013;39(8):943–949. DOI: 10.1055/s-0033-1357486 Epub 2013 Oct 10. PMID: 24114008Hoir isch-Cl apauch S, Nardi AE, Gr is JC, Brenner B. Mental disorders and thrombotic risk. Semin. Thromb. Hemost. 2013;39(8):943–949. DOI: 10.1055/s-0033-1357486 Epub 2013 Oct 10. PMID: 24114008Roche-Bayard P, Rossi R, Mnn J, Cordier J, Delahaye J. Left pulmonary artery thrombosis in chlorpromazineinduced lupus. Chest. 1990;98(6):1545.Roche-Bayard P, Rossi R, Mnn J, Cordier J, Delahaye J. Left pulmonary artery thrombosis in chlorpromazineinduced lupus. Chest. 1990;98(6):1545.Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356(9237):1219–1223. DOI: 10.1016/S0140-6736(00)02784-7. PMID: 11072939Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356(9237):1219–1223. DOI: 10.1016/S0140-6736(00)02784-7. PMID: 11072939

The authors declare that there are no conflicts of interest present.